5I4V

Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.61 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.208 
  • R-Value Observed: 0.210 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Discovery of a Novel, Orally Efficacious Liver X Receptor (LXR) beta Agonist.

Zheng, Y.Zhuang, L.Fan, K.Y.Tice, C.M.Zhao, W.Dong, C.Lotesta, S.D.Leftheris, K.Lindblom, P.R.Liu, Z.Shimada, J.Noto, P.B.Meng, S.Hardy, A.Howard, L.Krosky, P.Guo, J.Lipinski, K.Kandpal, G.Bukhtiyarov, Y.Zhao, Y.Lala, D.Van Orden, R.Zhou, J.Chen, G.Wu, Z.McKeever, B.M.McGeehan, G.M.Gregg, R.E.Claremon, D.A.Singh, S.B.

(2016) J Med Chem 59: 3264-3271

  • DOI: 10.1021/acs.jmedchem.5b02029
  • Primary Citation of Related Structures:  
    5I4V

  • PubMed Abstract: 
  • This article describes the application of Contour to the design and discovery of a novel, potent, orally efficacious liver X receptor β (LXRβ) agonist (17). Contour technology is a structure-based drug design platform that generates molecules using a context perceptive growth algorithm guided by a contact sensitive scoring function ...

    This article describes the application of Contour to the design and discovery of a novel, potent, orally efficacious liver X receptor β (LXRβ) agonist (17). Contour technology is a structure-based drug design platform that generates molecules using a context perceptive growth algorithm guided by a contact sensitive scoring function. The growth engine uses binding site perception and programmable growth capability to create drug-like molecules by assembling fragments that naturally complement hydrophilic and hydrophobic features of the protein binding site. Starting with a crystal structure of LXRβ and a docked 2-(methylsulfonyl)benzyl alcohol fragment (6), Contour was used to design agonists containing a piperazine core. Compound 17 binds to LXRβ with high affinity and to LXRα to a lesser extent, and induces the expression of LXR target genes in vitro and in vivo. This molecule served as a starting point for further optimization and generation of a candidate which is currently in human clinical trials for treating atopic dermatitis.


    Organizational Affiliation

    Vitae Pharmaceuticals, Inc. , 502 W. Office Center Drive, Fort Washington, Pennsylvania 19034, United States.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Oxysterols receptor LXR-beta,Nuclear receptor coactivator 2 AE270Homo sapiensMutation(s): 6 
Gene Names: NR1H2LXRBNERUNRNCOA2BHLHE75SRC2TIF2
Find proteins for P55055 (Homo sapiens)
Explore P55055 
Go to UniProtKB:  P55055
NIH Common Fund Data Resources
PHAROS:  P55055
Find proteins for Q15596 (Homo sapiens)
Explore Q15596 
Go to UniProtKB:  Q15596
NIH Common Fund Data Resources
PHAROS:  Q15596
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
Retinoic acid receptor RXR-beta,Nuclear receptor coactivator 2 BF255Homo sapiensMutation(s): 1 
Gene Names: RXRBNR2B2NCOA2BHLHE75SRC2TIF2
Find proteins for P28702 (Homo sapiens)
Explore P28702 
Go to UniProtKB:  P28702
NIH Common Fund Data Resources
PHAROS:  P28702
Find proteins for Q15596 (Homo sapiens)
Explore Q15596 
Go to UniProtKB:  Q15596
NIH Common Fund Data Resources
PHAROS:  Q15596
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
67S
Query on 67S

Download Ideal Coordinates CCD File 
A, E
{2-[(2R)-4-[4-(hydroxymethyl)-3-(methylsulfonyl)phenyl]-2-(propan-2-yl)piperazin-1-yl]-4-(trifluoromethyl)pyrimidin-5-yl}methanol
C21 H27 F3 N4 O4 S
FPVIRRAMNBCEDK-KRWDZBQOSA-N
 Ligand Interaction
External Ligand Annotations 
IDBinding Affinity (Sequence Identity %)
67SKi:  3   nM  BindingDB
67SEC50:  6   nM  BindingDB
67SEC50:  21   nM  BindingDB
67SEC50:  4   nM  BindingDB
67SIC50:  10000   nM  BindingDB
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.61 Å
  • R-Value Free: 0.248 
  • R-Value Work: 0.208 
  • R-Value Observed: 0.210 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 68.637α = 90
b = 101.221β = 90
c = 143.274γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data reduction
HKL-2000data scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-06-29
    Type: Initial release